Hypothesis

Age‑dependent loss of mitochondrial OGG1‑1b permits 8‑oxoG accumulation in mtDNA, which triggers a retrograde signaling cascade that directly suppresses nuclear BER enzymes (OGG1, APE1, Polβ) through NAD+ depletion and cGAS‑STING activation.

Mechanistic Model

1. mtDNA damage – Reduced OGG1‑1b activity lets 8‑oxoG persist in mitochondrial genomes [https://pmc.ncbi.nlm.nih.gov/articles/PMC10247526/].
2. Retrograde signal – Oxidized mtDNA is released into the cytosol, where it is sensed by cGAS, producing STING‑dependent type‑I IFN signaling.
3. IFN‑mediated transcriptional repression – IRF1, downstream of STING, binds promoters of nuclear BER genes (OGG1, APE1, Polβ) and reduces their expression, a mechanism observed in interferon‑treated neurons.
4. Metabolic amplification – Chronic STING activation consumes NAD+ via PARP1, lowering the NAD+/NADH ratio and further inhibiting SIRT1‑dependent deacetylation of APE1, decreasing its activity [https://www.aginganddisease.org/EN/10.14336/AD.2022.0331].
5. Vicious loop – Declining nuclear BER raises nuclear 8‑oxoG, which augments mitochondrial ROS production, reinforcing mtDNA damage.

Predictions & Tests

• Prediction 1: In aged neurons, cytosolic mtDNA fragments and phospho‑STING levels will correlate inversely with nuclear OGG1, APE1, and Polβ protein amounts.
  • Test: Isolate cytosol from young vs. aged mouse hippocampus, quantify mtDNA by qPCR and STING phosphorylation by Western blot; correlate with nuclear BER enzyme levels.
• Prediction 2: Pharmacological inhibition of cGAS

Morning light exposure within the first hour of waking activates melanopsin‑expressing retinal ganglion cells, phase‑advancing the suprachiasmatic nucleus and suppressing melatonin [[https://pmc.ncbi.nlm.nih.gov/articles/PMC12989132/]]. Beyond circadian alignment, this acute photic signal triggers a sympathetic surge that elevates norepinephrine release in the perivascular space of the brain. Norepinephrine drives aquaporin‑4 (AQP4) polarization toward astrocytic endfeet, a key step that increases glymphatic convective flow during subsequent sleep [[https://www.nature.com/articles/nn.4572/]]. Enhanced glymphatic clearance removes metabolic waste such as amyloid‑β and lactate, reducing interstitial pressure and promoting smoother transitions between NREM stages. We hypothesize that individuals who receive ≥3000 lux melanopic equivalent daylight illuminance (mEDI) for 60 minutes immediately after awakening will show a ≥15 % increase in overnight glymphatic influx (measured by CSF‑to‑serum ratio of inert tracer) and consequently achieve sleep efficiency >90 % (sleep time/time in bed) compared with a dim‑light control (<50 lux).

Testable prediction: In a within‑subject crossover design, participants undergo two 3‑day conditions separated by a washout. Condition A: bright outdoor light (>3000 lux) or blue‑enriched indoor light matched for mEDI within 5 minutes of waking. Condition B: identical timing but with light filtered to <50 lux. On night 3 of each condition, intrathecal infusion of a fluorescent tracer quantifies glymphatic influx via MRI‑based kinetic modeling, while po

Hypothesis

Chronic pain sensitivity reflects adrenal‑driven neuroimmune aging: a high cortisol/DHEAS awakening ratio drives blood‑brain barrier leakage, microglial priming, and central sensitization, which in turn lowers pain thresholds and accelerates epigenetic aging independently of chronological age.

Mechanistic rationale

1. Adrenal glucocorticoid excess – With age, cortisol secretion remains relatively stable while DHEAS falls, raising the cortisol/DHEAS ratio. Elevated glucocorticoids increase expression of endothelial adhesion proteins and reduce tight‑junction integrity, permitting peripheral cytokines and catecholamines to enter the CNS [[https://pmc.ncbi.nlm.nih.gov/articles/PMC12357812/]].
2. Blood‑brain barrier (BBB) compromise – Leakage allows IL‑1β, TNF‑α, and norepinephrine to activate perivascular macrophages and microglia. Primed microglia release prostaglandin E2 and BDNF, enhancing neuronal excitability in spinal dorsal horn circuits [[https://pubmed.ncbi.nlm.nih.gov/25428852/]].
3. Central sensitization and pain thresholds – Heightened microglial signaling lowers the activation threshold of nociceptive neurons, manifesting as reduced heat and pressure pain tolerance in quantitative sensory testing [[https://pmc.ncbi.nlm.nih.gov/articles/PMC5621604/]].
4. Feedback to epigenetic aging – Persistent neuroinflammation sustains HPA‑axis activation, driving glucocorticoid‑responsive transcription factors (e.g., NF‑κB, GR) that alter DNA methylation patterns at aging‑related CpG sites. Simultaneously, loss of DHEA‑mediated glucocorticost

Hypothesis

Combining intermittent dasatinib+quercetin (D+Q) with a low‑dose AMPK activator (e.g., metformin) creates a metabolic window that enhances natural killer (NK) cell–mediated senescent cell clearance, thereby prolonging the pharmacodynamic effect of senolytics and preventing the observed rebound in senescence biomarkers.

Mechanistic rationale

1. AMPK activation boosts NK cytotoxicity – Metformin increases AMPK activity in NK cells, upregulating perforin, granzyme B, and the expression of D1‑like dopamine receptors that sensitize NK cells to senescent‑cell‑associated signals【https://doi.org/10.1038/s41419-022-04562-w】.
2. Metabolic priming reduces SASP – AMPK signaling suppresses mTORC1, lowering NF‑κB‑driven SASP production in residual senescent cells, making them less immunosuppressive and more visible to immune surveillance【https://pmc.ncbi.nlm.nih.gov/articles/PMC12456441】.
3. Synergistic senolytic window – D+Q induces apoptosis of a bulk of senescent cells; the ensuing transient increase in intracellular AMPK (due to cellular stress) synergizes with exogenous metformin, creating a period where NK cells are both more active and senescent cells are less able to evade clearance.

Testable predictions

• In a randomized, double‑blind, placebo‑controlled trial of older adults with high baseline T‑cell p16^INK4A (top tertile), three arms will be compared: (i) D+Q alone (standard intermittent schedule), (ii) D+Q + low‑dose metformin given daily during the 2‑day senolytic window and continued for 2 weeks post‑dose, (iii) metformin alone.
• Prim

Hypothesis

Rapamycin does not extend lifespan by repairing aging damage; instead it pharmacologically induces a facultative diapause‑like state that activates conserved stress‑response programs evolved for surviving transient famine. This state mimics the signaling periphery of caloric restriction (CR) without reproducing CR’s deep metabolic re‑programming, so longevity arises from pathway modulation rather than from genuine cellular rejuvenation.

Mechanistic Rationale

• Signal mimicry, not metabolic depletion – CR lowers intracellular ATP/AMP ratio, depletes glycogen and lipid droplets, and drives a coordinated shift from glycolysis to β‑oxidation and autophagy [[https://academic.oup.com/biomedgerontology/article/73/1/29/3063959]]. Rapamycin reduces mTORC1 activity and up‑regulates autophagy but leaves ATP levels, glycogen, and lipid stores largely unchanged [[https://pmc.ncbi.nlm.nih.gov/articles/PMC9982835/]]. The drug therefore reproduces the signaling arm (AMPK‑ULK1, TFEB nuclear translocation) while bypassing the energetic arm that forces cells to catabolize reserves.
• Facultative diapause analogy – Many organisms enter a reversible dormancy (e.g., dauer, adult reproductive diapause) when nutrients fall, characterized by heightened stress resistance, reduced growth, and preserved energy stores [[https://www.science.org/doi/10.1126/sciadv.adw8410]]. Rapamycin‑treated mice show comparable increases in stress‑resistance markers (HSP70, SOD2) and unchanged adipose mass, fitting a diapause‑like physiology.
• Immune‑mediated disease mitigation – Chro

Hypothesis

Persistent JNK activation during cellular stress leads to phosphorylation of the autophagy receptor p62/SQSTM1, which drives its phase separation into cytoplasmic aggregates. We propose that the duration and kinase context of p62 phosphorylation determine whether these aggregates remain liquid‑like, autophagy‑competent structures or mature into solid, amyloid‑like scaffolds that sustain senescence‑associated secretory phenotype (SASP). Specifically, early JNK‑dependent phosphorylation of p62 at serine‑403 (S403) enhances its LC3‑interacting region (LIR) exposure and promotes liquid‑liquid phase separation (LLPS) that sequesters damaged proteins for autophagic clearance. Continued JNK activity recruits casein kinase 2 (CK2), which phosphorylates additional acidic residues (e.g., S409, S412) on p62, stabilizing β‑sheet interactions and converting the condensates into protease‑resistant, Thioflavin‑T‑positive aggregates. These solid p62 scaffolds then serve as platforms for NLRP3 inflammasome assembly and NF‑κB activation, locking the cell into a chronic inflammatory state.

Testable Predictions

1. Phospho‑switch detection – In senescent fibroblasts, p62 S403 phosphorylation will peak early (6‑12 h after stress) and correlate with increased LC3‑II puncta and high autophagic flux, whereas later time points (24‑48 h) will show accumulation of p62 S409/S412 phosphorylation alongside Thioflavin‑T positivity and reduced LC3 turnover.
2. CK2 inhibition blocks solidification – Treatment with a selective CK2 inhibitor (CX‑4945) during the late phase will

Hypothesis

During sleep, autophagic flux in adrenal zona reticularis cells acts as a selective editor that removes damaged mitochondria and misfolded steroidogenic enzymes, thereby preserving DHEA synthesis capacity. Chronic sleep disruption blunts this nocturnal autophagy, shifting the zona reticularis toward a catabolic state marked by accumulated oxidative damage and accelerated DHEA loss.

Mechanistic Basis

The glymphatic autopsy metaphor extends to peripheral endocrine organs: sleep provides a stereotyped low‑glucocorticoid window that permits AMPK activation and ULK1‑dependent autophagy initiation. In aging, flattened cortisol rhythms elevate nighttime glucocorticoid receptor (GR) signaling, which suppresses AMPK via increased REDD1 expression and mTORC1 reactivation. Consequently, autophagosome formation (LC3‑II conversion) falls, p62 accumulates, and damaged CYP17A1 and StAR proteins are not cleared. The resulting enzymatic deficit reduces pregnenolone conversion to DHEA, reinforcing the observed 1–2 % yearly decline.

Testable Predictions

1. Mice subjected to chronic fragmented sleep will show reduced LC3‑II/I ratios and elevated p62 specifically in zona reticularis (but not zona fasciculata) compared with rested controls.
2. This autophagy deficit will correlate with lower adrenal DHEA output and blunted corticosterone awakening response (CAR analogue).
3. Pharmacological enhancement of autophagy (e.g., spermidine or low‑dose rapamycin administered during the rest phase) will restore LC3‑II flux, rescue DHEA synthesis, and normalize the CAR analogue witho

Hypothesis

Chronic low‑grade SASP from senescent adipose tissue primes microglia, leading to heightened NLRP3 inflammasome activity in the hippocampus and suppressed neurogenesis. A single senolytic dose clears a fraction of these cells, but residual SASP continues to drive microglial priming unless mTORC1 activity is transiently inhibited shortly after clearance. We hypothesize that administering rapamycin 24 h after a dasatinib + quercetin (D+Q) senolytic session will synergistically reduce hippocampal IL‑1β, restore BDNF‑dependent neurogenesis, and improve spatial memory in aged mice.

Mechanistic Rationale

• Senescent adipocytes secrete IL‑6, CCL2, and MMP‑9 that cross the blood‑brain barrier and engage microglial TLR4/CCR2 receptors [Senolytics selectively eliminate senescent cells].
• This chemokine surge primes microglia for a second hit; subsequent D+Q‑induced cell death releases DAMPs that trigger microglial NLRP3 inflammasome activation, increasing IL‑1β and TNF‑α production [Transplanting senescent cells causes dysfunction].
• Rapamycin inhibits mTORC1, suppressing the translation of SASP components and attenuating NLRP3 inflammasome assembly [Rapamycin inhibits mTORC1 to suppress SASP].
• Temporal separation allows senolytic‑induced debris to be cleared before mTOR inhibition blocks the SASP rebound, thereby preventing chronic microglial activation.

Predictions

1. Biochemical – In 20‑month‑old

Hypothesis

Gut‑derived indole‑3‑propionic acid (IPA) accumulates with age and directly amplifies mTORC1 activity in senescent cells, thereby locking autophagy in a suppressed state.

Mechanistic Model

• IPA uptake: Aged epithelium shows increased expression of the aromatic amino acid transporter SLC7A5, raising intracellular IPA levels【https://doi.org/10.1126/sciadv.adw8410】.
• mTORC1 activation: IPA binds to the lysosomal sensor SLC38A9, promoting Rag GTPase loading and lysosomal mTORC1 recruitment, a step that is known to drive the TOR‑Autophagy Spatial Coupling Compartment (TASCC)【https://doi.org/10.1083/jcb.201610113】.
• LAMP2A destabilization: Sustained mTORC1 signaling phosphorylates LAMP2A on serine‑14, accelerating its proteasomal turnover and dropping its half‑life from ~38 h to ~26 h, matching the observed decline in senescent cells【https://pmc.ncbi.nlm.nih.gov/articles/PMC9835585】.
• Feedback loop: Reduced autophagic flux diminishes clearance of damaged mitochondria, increasing mtDNA release and cGAS‑STING activation, which further sustains NF‑κB‑driven SASP and reinforces the senescent phenotype.

Testable Predictions

1. Correlation: Serum IPA concentrations will positively correlate with tissue‑specific p‑S6K (mTORC1 read‑out) and inversely with LC3‑II/I ratio in aged mice and humans.
2. Loss‑of‑function: Genetic knockout of SLC7A5 in intestinal epithelial cells of aged mice will lower hepatic IPA, reduce p‑S6K, increase LAMP2A stability, and restore autophagic flux compared with wild‑type controls.
3. Pharmacologic blockade

Hypothesis

Aged B cells show reduced insulin receptor signaling, leading to sustained nuclear FOXO1 activity that blocks AID transcription and recruitment to immunoglobulin loci, thereby lowering somatic hypermutation (SHM) and class‑switch recombination (CSR). The resulting low‑affinity, poorly sialylated IgG amplifies inflammaging through REST/NF‑κB activation. Restoring insulin signaling in B cells should rescue AID function, improve SHM quality, and normalize IgG glycosylation, extending healthspan.

Mechanistic rationale

• Insulin signaling normally phosphorylates FOXO1, excluding it from the nucleus and permitting E2A/E47‑driven AID transcription.
• In aging, hematopoietic stem cell myeloid bias and low IL‑7 reduce naïve B‑cell output, while chronic inflammation elevates serine kinases (e.g., mTORC1/S6K) that cause insulin receptor substrate‑1 (IRS‑1) serine phosphorylation, attenuating downstream AKT signaling.
• Consequently, FOXO1 remains dephosphorylated, binds the AID promoter, and recruits HDAC complexes that suppress transcription, compounding the noted E47 mRNA instability.
• Reduced AID activity diminishes both SHM and CSR, yielding antibodies with fewer replacement mutations in CDR/framework and altered Fc glycosylation (less sialylation) due to impaired B‑cell cytokine milieu (e.g., lower IL‑21, higher BAFF) that skews Golgi enzymes.
• Pro‑inflammatory IgG engages FcγRIIb on macrophages and dendritic cells, activating REST/NF‑κB pathways that further inhibit insulin signaling in a feed‑forward loop, linking B‑cell dysfunction to T‑cell immunosenescenc

Hypothesis

Aged B cell repertoires suffer from over‑consolidation driven by persistent IgG‑FcγRIIb signaling that raises activation thresholds and suppresses somatic hypermutation. Transient reduction of circulating IgG combined with low‑dose, intermittent TLR7/8 agonist exposure will lower this threshold, reactivate AID activity, and restore clonal diversity without causing autoimmunity.

Mechanistic Basis

Chronic IgG accumulation in senescent tissues engages the inhibitory FcγRIIb receptor on B cells, recruiting SHP‑1 phosphatase and dampening BCR‑mediated signals required for germinal center (GC) entry and AID induction【https://pmc.ncbi.nlm.nih.gov/articles/PMC2853364/】. This creates a self‑reinforcing loop: high IgG → stronger FcγRIIb inhibition → lower AID → reduced SHM → further oligoclonal dominance【https://pmc.ncbi.nlm.nih.gov/articles/PMC2667647/】. TLR7/8 signaling, when delivered in a tonic, sub‑inflammatory manner, can counteract FcγRIIb by activating MyD88‑dependent NF‑κB pathways that up‑regulate AID and promote GC re‑entry【https://pubmed.ncbi.nlm.nih.gov/26614343/】. The combination therefore predicts a synergistic reset: IgG depletion removes the brake, while TLR7/8 stimulation provides the gas.

Predictions

1. In aged mice, a 48‑hour anti‑IgG serum depletion followed by three weekly low‑dose imiquimod (TLR7/8 agonist) injections will increase GC B cell frequency by ≥2‑fold compared with either treatment alone.
2. High‑throughput Ig‑seq will show a significant rise in clonal richness (inverse Simpson index) and a shift toward lower clonal dominance (G

Hypothesis

Senescent cells are not merely passive accumulators of damage; they actively calibrate their inflammatory output through inducible phosphatases that act as a brake on JAK-STAT signaling. We propose that senescent fibroblasts up‑regulate SHP1 and SHP2 in response to persistent cytokine exposure, creating a negative‑feedback loop that limits SASP amplitude while preserving enough signaling to restrain neighboring stem‑cell proliferation. When this phosphatase‑mediated brake is experimentally removed, JAK‑STAT activity will surge, ISG expression will spike, and the SASP will shift toward a hyper‑inflammatory profile that triggers paracrine senescence and tissue fibrosis. Conversely, pharmacological enhancement of SHP1/2 activity will dampen SASP, relieve frailty‑associated phenotypes, but will also lift the restraint on stem‑cell division, increasing the risk of hyperplastic lesions or tumorigenesis in aged tissues.

Testable predictions

1. Phosphatase induction – RNA‑seq or proteomics of TNFα‑induced senescent human fibroblasts (day 3–6) will show significant up‑regulation of PTPN6 (SHP1) and PTPN11 (SHP2) relative to proliferating controls [https://www.aging-us.com/article/101328/text].
2. Functional brake – CRISPR‑mediated knock‑down of SHP1/2 in senescent cells will increase STAT1/3 phosphorylation, elevate ISG transcripts (e.g., MX1, ISG15), and boost secretion of IL‑6, IL‑8, and MMPs after 24 h [https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.650250/full].
3. Phenotypic shift – Phosphatase‑defi

Background

AA amyloidosis remains an underdiagnosed complication of persistently active rheumatic diseases — particularly rheumatoid arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis — with renal involvement often detected only at advanced proteinuria stages. Current surveillance relies on serum amyloid A (SAA) thresholds, but single-timepoint SAA levels correlate poorly with amyloid fibril deposition kinetics due to isoform-specific fibrillogenesis.

Hypothesis

We hypothesize that the longitudinal SAA1/SAA2 isoform ratio trajectory, measured via mass spectrometry-based targeted proteomics at 3-month intervals, combined with rectal mucosal brush biopsy proteomics detecting sub-histological amyloid precursor aggregation signatures, can predict clinical AA amyloidosis onset 12–30 months before Congo Red-positive tissue biopsy with >80% sensitivity and >85% specificity.

Mechanistic Rationale

1. SAA1 isoform predominance drives fibrillogenesis: SAA1.1 and SAA1.3 allelic variants exhibit differential amyloidogenic propensity. A rising SAA1/SAA2 ratio over time — independent of absolute SAA concentration — reflects a shift toward the more fibrillogenic isoform pool.
2. Rectal mucosal proteomics as sentinel tissue: The rectal mucosa is the earliest accessible site for subclinical amyloid deposition. Mass spectrometry on brush biopsies can detect SAA-derived peptide fragments and glycosaminoglycan-binding signatures consistent with pre-fibrillar oligomer accumulation, preceding Congo Red staining positivity by months.
3. **Traject

Hypothesis

Restoring elastin-rich extracellular matrix in the aged vocal fold lamina propria will reactivate satellite cell-mediated thyroarytenoid muscle regeneration by reducing elastin-derived inhibitory peptides that suppress myogenic differentiation.

Mechanistic Rationale

Aging increases collagen I/III and decreases elastin in the lamina propria [alterations-in-extracellular-matrix-composition-in-the-aging]. Elastin degradation generates bioactive peptides that can bind integrin αvβ3 on resident progenitor cells. In other tissues, such peptides activate TGF‑β/Smad3 signaling, promoting a fibrogenic phenotype and inhibiting satellite cell proliferation and differentiation [satellite-cell-regeneration-injury]. We propose that a similar mechanism operates in the larynx: loss of intact elastin shifts the local niche from supportive to inhibitory, directly contributing to the observed decline in thyroarytenoid satellite cell mitotic activity with age.

Sex hormone modulation of ECM gene expression [sex-hormones-ecm-gene-expression] may amplify or dampen this effect, explaining individual variability in presbyphonia progression.

Experimental Design

Model: Aged (24‑month) male and female Fischer rats; young (3‑month) controls. Intervention: Intralaminar propria injection of recombinant human tropoelastin or an elasti

Hypothesis

Baseline heart-rate variability (HRV) predicts the magnitude of anxiety reduction following supplementation with Lactobacillus plantarum JYLP-326, reflecting individual differences in vagal afferent readiness to transmit gut-derived signals.

Mechanistic Rationale

Recent work shows that Lactobacillus plantarum JYLP-326 restores beneficial taxa such as Bacteroides, Bifidobacterium, Prevotella and Roseburia, shifts tryptophan metabolism toward serotonin, and lowers proinflammatory cytokines [https://pmc.ncbi.nlm.nih.gov/articles/PMC12386460/][https://pmc.ncbi.nlm.nih.gov/articles/PMC10077425/]. These changes increase luminal serotonin and indole-derived metabolites that activate enterochromaffin cells and vagal afferents via 5-HT3 receptors and transient receptor potential channels. The strength of this gut-to-brain signal depends on the excitability of vagal fibers, which is modulated by their baseline tone. High baseline HRV indicates greater parasympathetic reserve and heightened sensitivity of vagal afferents, allowing microbiota‑induced neurochemical changes to be efficiently transmitted to the nucleus tractus solitarius and subsequently to limbic circuits that regulate anxiety. Conversely, low baseline HRV reflects reduced vagal excitability, limiting signal propagation despite equivalent microbiota shifts.

Testable Predictions

1. Participants with baseline HRV above the cohort median will show a larger decrease in HAMA/HDRS scores after 3 weeks of Lactobacillus plantarum JYLP-326 (≥1.5×10¹⁰ CFU/day) compared with those below the median.
2. The s

Hypothesis

Core idea: Oral administration of Lactiplantibacillus plantarum Lp815 increases vagal afferent signaling through a combined GABA‑short‑chain fatty acid (SCFA) mechanism, producing early detectable shifts in non‑linear heart‑rate‑variability (HRV) metrics before measurable changes in systemic GABA or anxiety scores.

Rationale

• Pre‑clinical work shows Lactobacillus strains reduce stress‑induced behaviors via vagal pathways and increase luminal GABA (Lactobacillus‑Based Probiotics Reduce the Adverse Effects of Stress in Rodents)[https://www.frontiersin.org/journals/behavioral-neuroscience/articles/10.3389/fnbeh.2021.642757/full].
• Human RCT of Lp815 raised urinary GABA and lowered GAD‑7 scores (Lactiplantibacillus plantarum Lp815 improves sleep and increases urinary GABA)[https://pmc.ncbi.nlm.nih.gov/articles/PMC12816741/].
• SCFA‑producing microbes stimulate colonic enterochromaffin cells to release 5‑HT and activate vagal afferents (Gut microbiota as a novel target for treating anxiety and depression)[https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1664800/full].
• HRV non‑linear indices such as sample entropy (SampEnt) and detrended fluctuation analysis α1 (DFA α1) reflect vagal responsiveness and change earlier than time‑domain measures (Heart rate variability: a multidimensional perspective)[https://pmc.ncbi.nlm.nih.gov/articles/PMC12630126/].

Novel Mechanistic Insight

We propose that Lp815’s GABA production does not act alone; instead, GABA released in the gut lumen synergizes with locally generated SCFAs (acetate

Hypothesis

Age‑dependent up‑regulation of the lncRNA NEAT1 promotes DRP1‑mediated mitochondrial fission in vascular smooth muscle cells (VSMCs), generating reactive oxygen species that simultaneously drive tropoelastin loss and VSMC osteogenic transdifferentiation, leading to arterial calcification that can be reversed by targeting NEAT1 or DRP1.

Mechanistic Model

1. NEAT1 scaffolds DRP1 to the outer mitochondrial membrane, increasing GTPase activity and fission.
2. Mitochondrial fission elevates ROS via electron‑transport chain leak, activating NF‑κB and MAPK pathways.
3. ROS‑dependent NF‑κB up‑regulates MMP‑2 and MMP‑9, which degrade elastin fibers; released elastin peptides act as DAMPs that suppress tropoelastin transcription through Hippo‑YAP/TAZ signaling.
4. ROS also stabilizes HIF‑1α, boosting BMP‑2 expression and SMAD1/5/8 signaling, while mtDNA released into the cytosol activates cGAS‑STING, inducing IRF3‑driven Runx2 expression.
5. Combined BMP‑2/SMAD and Runx2 pathways push VSMCs toward an osteogenic phenotype, evidenced by ↑ALP, ↓SM22α, and calcium deposition.
6. Inhibition of NEAT1 or DRP1 reduces fission, lowers ROS, restores tropoelastin synthesis, and blocks osteogenic shift, making calcification reversible.

Testable Predictions

• VSMCs from old mice show higher NEAT1, phospho‑DRP1 (Ser616), mitochondrial fragmentation, and ROS compared with young cells.
• NEAT1 knock‑down (ASO) or DRP1 inhibition (Mdivi‑1) decreases ROS, MMP activity, and elastin fragmentation while increasing tropoelastin mRNA and protein.
• Under osteog

Berberine’s activation of AMPK triggers the ULK1 complex, initiating autophagy that can clear intracellular aggregates. During sleep, the glymphatic system convects cerebrospinal fluid through the brain parenchyma, extracting extracellular tau and other metabolites. We hypothesize that administering berberine at the onset of non‑rapid eye movement (NREM) sleep will amplify this nocturnal clearance by coupling AMPK‑driven autophagy with the glymphatic influx phase, while avoiding the synaptic loss seen with chronic AMPK hyper‑activation.

Mechanistically, AMPK phosphorylation of ULK1 not only promotes autophagosome formation but also upregulates aquaporin‑4 (AQP4) expression and its perivascular polarization, a key determinant of glymphatic efficiency. Simultaneously, berberine’s inhibition of PCSK9 lowers circulating LDL, reducing endothelial oxidative stress that can impair perivascular fluid channels. In microglia, transient AMPK activation shifts the phenotype toward a pro‑clearance state, decreasing cytokine‑mediated constriction of arterial pulsatility that drives glymphatic flow. Together, these effects create a time‑restricted window where extracellular waste is both autophagocytosed within cells and flushed via the glymphatic conduit.

Crucially, the dose‑dependent nature of AMPK signaling predicts a therapeutic window: low‑to‑moderate berberine concentrations (≈5–10 mg/kg in mice) activate AMPK sufficiently to enhance autophagy and AQP4 polarity without sustained activation that drives excessive synaptic pruning. High concentrations or continuous exposure would ris